Aurora Cannabis has received an unsolicited takeover proposal from Curaleaf offering $4 per share, combining cash and Curaleaf shares. Aurora's board is reviewing the offer carefully, noting the price is lower than past trading values and emphasizing their ongoing strategic plans, including recent acquisitions and expansion in Europe. Aurora has not made any decision and will form a special committee to evaluate the proposal while continuing normal operations. Shareholders are advised no action is needed currently, and further comments will depend on future developments or legal requirements.
Curaleaf Holdings has made a hostile bid to acquire Aurora Cannabis, proposing $4 per share through a combination of Curaleaf shares and $0.75 cash per Aurora share. This offer represents a 45% premium over Aurora's recent average price and aims to m...
Curaleaf Holdings has proposed to acquire Aurora Cannabis by offering US$4.00 per share, including cash and Curaleaf shares, representing a 45% premium over Aurora's recent trading price. The deal aims to combine Aurora's EU-GMP cultivation and manuf...
Aurora Cannabis held its 2026 Annual General Meeting virtually, with 26.86% of shares represented. Shareholders re-elected all nominated directors with over 85% approval and approved Ernst & Young LLP as auditors for the coming year. The advisory vot...
